Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 3:37 AM
Ignite Modification Date: 2025-12-26 @ 2:21 AM
NCT ID: NCT02500602
Description: Participants were asked about any changes in health or existing symptoms at each visit.
Frequency Threshold: 5
Time Frame: AEs collected from baseline (if baseline lasted longer than one appointment) through follow up (12 week treatment phase and 6 week follow up - approximately 20 weeks)
Study: NCT02500602
Study Brief: CAP: Doxazosin in the Treatment of Co-Occurring PTSD and Alcohol Use Disorders
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Doxazosin Participants randomly assigned to receive doxazosin (target dose of 16 mg/day). doxazosin: active medication 0 None 12 74 48 74 View
Placebo Participants randomly assigned to receive Placebo pill placebo: placebo pill 0 None 9 70 40 70 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Dehydration SYSTEMATIC_ASSESSMENT General disorders MedDRA View
Chest Pain SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA View
Hemorrhoids SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA View
Pancreatitis SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA View
Hernia SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA View
Fracture SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA View
Depression SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA View
Suicidal Ideation/Attempt SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA View
Anger/Frustration SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA View
Homicidal Ideation/Aggression SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA View
Substance Use SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA View
Panic Attack/Anxiety SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA View
Diabetes Complications SYSTEMATIC_ASSESSMENT Endocrine disorders MedDRA View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Hypotension SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA View
Diarrhea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA View
Fatigue SYSTEMATIC_ASSESSMENT General disorders MedDRA View
Generalized Pain SYSTEMATIC_ASSESSMENT General disorders MedDRA View
Accident/Injury SYSTEMATIC_ASSESSMENT General disorders MedDRA View
Joint/Muscle Pain SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA View
Drowsiness/Grogginess SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA View
Sleep Problems SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA View
Emotional Distress SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA View
Depression SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA View
Hypertension SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA View
Stomach Virus/Cramping/Nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA View
Cold/Sinus/Congestion SYSTEMATIC_ASSESSMENT General disorders MedDRA View
Dizziness/Lightheadedness SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA View
Vivid Dreams/Nightmares SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA View